Xp [XP] vs Morgan Stanley [MS] Detailed Stock Comparison
Xp
NASDAQ
Loading...
Morgan Stanley
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Xp wins in 11 metrics, Morgan Stanley wins in 7 metrics, with 0 ties. Xp appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Xp | Morgan Stanley | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.13 | 16.40 | Xp |
| Price-to-Book Ratio | 0.38 | 2.35 | Xp |
| Debt-to-Equity Ratio | 774.54 | 438.54 | Morgan Stanley |
| PEG Ratio | 0.45 | 1.01 | Xp |
| EV/EBITDA | 18.32 | N/A | N/A |
| Profit Margin (TTM) | 29.27% | 22.49% | Xp |
| Operating Margin (TTM) | 30.54% | 34.12% | Morgan Stanley |
| EBITDA Margin (TTM) | 30.54% | 34.12% | Morgan Stanley |
| Return on Equity | 23.32% | 14.13% | Xp |
| Return on Assets (TTM) | 1.47% | 1.16% | Xp |
| Free Cash Flow (TTM) | $1.98B | $-2.10B | Xp |
| Dividend Yield | 3.27% | 2.15% | Xp |
| 1-Year Return | -17.50% | 41.37% | Morgan Stanley |
| Price-to-Sales Ratio (TTM) | 0.51 | 3.52 | Xp |
| Enterprise Value | $-12.06B | $158.15B | Morgan Stanley |
| EV/Revenue Ratio | -3.90 | 2.41 | Xp |
| Gross Profit Margin (TTM) | 22.20% | N/A | N/A |
| Revenue per Share (TTM) | $31 | $41 | Morgan Stanley |
| Earnings per Share (Diluted) | $1.60 | $8.83 | Morgan Stanley |
| Beta (Stock Volatility) | 1.14 | 1.32 | Xp |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Xp vs Morgan Stanley Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Xp | 1.76% | -7.02% | -4.66% | -13.30% | 10.38% | 36.92% |
| Morgan Stanley | 2.76% | -3.01% | 2.54% | 14.96% | 9.38% | 15.44% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Xp | -17.50% | -24.16% | -67.49% | -57.12% | -57.12% | -57.12% |
| Morgan Stanley | 41.37% | 65.93% | 172.34% | 323.02% | 475.47% | 179.36% |
Performance & Financial Health Analysis: Xp vs Morgan Stanley
| Metric | XP | MS |
|---|---|---|
| Market Information | ||
| Market Cap | $8.54B | $231.12B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 5,490,605 | 4,617,060 |
| 90 Day Avg. Volume | 5,539,388 | 5,290,947 |
| Last Close | $16.45 | $148.02 |
| 52 Week Range | $10.82 - $20.64 | $94.09 - $149.08 |
| % from 52W High | -20.28% | -0.71% |
| All-Time High | $53.08 (Aug 30, 2021) | $148.90 (Aug 22, 2025) |
| % from All-Time High | -69.01% | -0.59% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.11% |
| Quarterly Earnings Growth | 0.18% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.22% |
| Operating Margin (TTM) | 0.31% | 0.34% |
| Return on Equity (TTM) | 0.23% | 0.14% |
| Debt to Equity (MRQ) | 774.54 | 438.54 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $42.26 | $61.59 |
| Cash per Share (MRQ) | $467.75 | $352.68 |
| Operating Cash Flow (TTM) | $1.96B | $-17,670,000,640 |
| Levered Free Cash Flow (TTM) | $831.23M | $12.80B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.27% | 2.15% |
| Last 12-Month Dividend | $0.65 | $2.79 |
Valuation & Enterprise Metrics Analysis: Xp vs Morgan Stanley
| Metric | XP | MS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.13 | 16.40 |
| Forward P/E | 9.70 | 18.26 |
| PEG Ratio | 0.45 | 1.01 |
| Price to Sales (TTM) | 0.51 | 3.52 |
| Price to Book (MRQ) | 0.38 | 2.35 |
| Market Capitalization | ||
| Market Capitalization | $8.54B | $231.12B |
| Enterprise Value | $-12,059,655,315 | $158.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -3.90 | 2.41 |
| Enterprise to EBITDA | 18.32 | N/A |
| Risk & Other Metrics | ||
| Beta | 1.14 | 1.32 |
| Book Value per Share (MRQ) | $42.26 | $61.59 |
Financial Statements Comparison: Xp vs Morgan Stanley
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | XP | MS |
|---|---|---|
| Revenue/Sales | $327.78M | $16.52B |
| Cost of Goods Sold | $260.39M | N/A |
| Gross Profit | $67.39M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-219.34M | N/A |
| EBITDA | $-199.21M | N/A |
| Pre-Tax Income | $240.73M | $5.54B |
| Income Tax | $-641,678 | $1.17B |
| Net Income (Profit) | $241.37M | $4.37B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | XP | MS |
|---|---|---|
| Cash & Equivalents | $2.21B | $60.84B |
| Total Current Assets | $27.39B | N/A |
| Total Current Liabilities | $34.60B | N/A |
| Long-Term Debt | N/A | $303.93B |
| Total Shareholders Equity | $4.07B | $107.85B |
| Retained Earnings | $466.59M | $107.65B |
| Property, Plant & Equipment | $149.20M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | XP | MS |
|---|---|---|
| Operating Cash Flow | $39.56M | $-67.29B |
| Capital Expenditures | $-7.89M | $-713.00M |
| Free Cash Flow | $849.33M | $-24.69B |
| Debt Repayment | $-136.90M | $-20.85B |
| Common Stock Repurchase | $-76.18M | $-2.03B |
Short Interest & Institutional Ownership Analysis
| Metric | XP | MS |
|---|---|---|
| Shares Short | 25.43M | 14.60M |
| Short Ratio | 4.84 | 2.55 |
| Short % of Float | 0.06% | 0.01% |
| Average Daily Volume (10 Day) | 5,490,605 | 4,617,060 |
| Average Daily Volume (90 Day) | 5,539,388 | 5,290,947 |
| Shares Outstanding | 98.98M | 1.61B |
| Float Shares | 423.57M | 1.21B |
| % Held by Insiders | 0.00% | 0.24% |
| % Held by Institutions | 0.92% | 0.63% |
Dividend Analysis & Yield Comparison: Xp vs Morgan Stanley
| Metric | XP | MS |
|---|---|---|
| Last 12-Month Dividend | $0.65 | $2.79 |
| Last 12-Month Dividend Yield | 3.27% | 2.15% |
| 3-Year Avg Annual Dividend | $0.65 | $3.10 |
| 3-Year Avg Dividend Yield | 3.38% | 0.90% |
| 3-Year Total Dividends | $1.96 | $9.31 |
| Ex-Dividend Date | Dec 10, 2024 | Jan 31, 2025 |